Corporate/M&A & Private Equity

Band 3Asia-Pacific RegionAsia-Pacific 2021 View ranking table
chambers review
department information
chambers review
department information

Chambers Review

Chambers Research is conducted by 200 Research Analysts, across 200 jurisdictions and provides nearly 6,000 rankings tables. Annually we collect hundreds of thousands of responses from clients, the majority via in-depth interview. Learn more about our methodology.

What the team is known for

Notable presence in the M&A space, well versed in foreign direct investment and domestic transactions in a number of jurisdictions. Assists major Chinese clients on outbound mandates across Asia as well as advising on their investments into Europe and the USA. Maintains a focus on inbound transactions to Australia, with notable experience in tech-related deals. Widely recognised for its extensive global network, with noted expertise in Japan, Thailand, Indonesia and New Zealand. The practice also continues to represent a number of major investment banks.


A client appreciates that the team's lawyers "attach great importance to their client and are experts on complex M&A transactions. We have worked with many teams across different jurisdictions who closely cooperate, which is a lot of help for our cross-border projects,"

Other sources report: "They are flexible, responsive and they understand our business, our position and the commercial environment," additionally praising the team's "technical expertise and knowledge."

A client praises the team's ability to provide advice that serves the needs of business, commenting: "They are very good lawyers who understand my business and the law, and are able to develop very commercial solutions and provide strong legal advice."

One source is impressed by the group's "short reaction times, commercial awareness and ability to meet and exceed client expectations," adding: "The firm is able to pool resources from its international network to provide seamless service to cover cross-border and local issues."

Another source also endorses the team's "international deal experience, as well as local knowledge," adding: "They are flexible and commercial, and always try to provide solutions even in challenging circumstances."

A client reports: "The team really understand how to strategically help us from a commercial perspective. I find their performance to be very strong, thanks to their ability to intimately understand our business and commercial objectives."

DLA Piper is referred to as "an excellent firm, with high-calibre people, that is commercial and responsive."

One client reports: "They are great to work with and smooth in negotiations."

Another client speaks gratefully of "efficient and gracious customer service, with a high level of detail and accountability, as demonstrated throughout each phase of the acquisition process."

Work highlights

Acted for General Electric on its USD21.4 billion sale of the biopharma business of GE Life Sciences to Danaher.

Advised Pearson Education Asia on its strategic joint venture with China South Publishing & Media Group.

Advised CMH Capital on its investment in Shanghai Kedu Healthcare Tech, in connection with the company’s pre-IPO restructuring.

Acted for Pakiri Processors, a subsidiary of Foodstuffs North Island, in the acquisition of the business and assets of Leigh Fisheries and Leigh Bait.

Represented Saracen Mineral Holdings during its acquisition of Barrick Gold's 50% interest in the KCGM Joint Venture.

Advised LivaNova on its asset acquisition agreement in Thailand, including advice on corporate structure and foreign business licence issues.

Acted for OneConnect Financial Technology on its establishment of a Japanese joint venture with SBI Neo Financial Services in order to distribute its products in Japan.

Advised Singapore Technologies Engineering on its EUR250 million acquisition of Newtec.

Acted for Hyundai and Kia Motors on their EUR100 million investment in electric vehicle company Arrival.

Advised Reinventure on the USD90 million Series C fund-raising of FinAccel.

Acted for General Electric on its USD21.4 billion sale of the biopharma business of GE Life Sciences to Danaher.

Notable practitioners

Hong Kong-based David Kuo and Shanghai-based Li Qiang are key contacts for the Greater China practice. Grant Koch heads the firm's corporate practice in Australia.

Department Information

This content is provided by DLA Piper LLP.


You can learn more about our practice at

Corporate/M&A & Private Equity Department


Department location

160 Aldersgate Street


Greater London



View Firm Profile